Evaluating walking in patients with multiple sclerosis: which assessment tools are useful in clinical practice?
about
A group-delivered self-management program reduces spasticity in people with multiple sclerosis: A randomized, controlled pilot trial.An exploration of impaired walking dynamics and fatigue in multiple sclerosis.Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis.Extended-release dalfampridine in the management of multiple-sclerosis-related walking impairment.Monitoring gait in multiple sclerosis with novel wearable motion sensors.A machine learning approach for gait speed estimation using skin-mounted wearable sensors: From healthy controls to individuals with multiple sclerosis.Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinicA comparison of 12 weeks of pilates and aquatic training on the dynamic balance of women with mulitple sclerosis.Treatment patterns and health care resource utilization associated with dalfampridine extended release in multiple sclerosis: a retrospective claims database analysis.Fampridine and quality of life in individuals with multiple sclerosisAssessment of Early Evidence of Multiple Sclerosis in a Prospective Study of Asymptomatic High-Risk Family Members.No relevant impact of ambient temperature on disability measurements in a large cohort of patients with multiple sclerosis.Is physical exercise a multiple sclerosis disease modifying treatment?Footfall placement variability and falls in multiple sclerosis.Defining the Role of Physiotherapy in Palliative Care in Multiple Sclerosis.Utilization of the Expanded Disability Status Scale as a distinctive instrument for walking impairment in persons with multiple sclerosis with mild disability.Evaluation of the Multiple Sclerosis Walking Scale-12 (MSWS-12) in a Dutch sample: Application of item response theory.Evaluation of patients with multiple sclerosis using reverse nutech functional score and expanded disability status scale after human embryonic stem cell therapy.The association between observed mobility and quality of life in the near elderlyEffects of walking direction and cognitive challenges on gait in persons with multiple sclerosis.A pooled analysis of two phase 3 clinical trials of dalfampridine in patients with multiple sclerosis.Correlation analysis of visual analogue scale and measures of walking ability in multiple sclerosis patients.The reliability, precision and clinically meaningful change of walking assessments in multiple sclerosis.Evaluation of the Keeogo™ Dermoskeleton.Clinical outcome measures for progressive MS trials.Pharmacological and non-pharmacological therapies of cognitive impairment in multiple sclerosis.Technologies for Advanced Gait and Balance Assessments in People with Multiple Sclerosis.Changes in spatiotemporal gait parameters following intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy.Bipedal Hopping Reveals Evidence of Advanced Neuromuscular Aging Among People With Mild Multiple Sclerosis.Turning is an important marker of balance confidence and walking limitation in persons with multiple sclerosis.Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine.Development of a gait module to complement the 12-item Multiple Sclerosis Walking Scale: a mixed methods studyEffects of Rehabilitation on Gait Pattern at Usual and Fast Speeds Depend on Walking Impairment Level in Multiple Sclerosis
P2860
Q33692249-919774FE-764A-4446-BB26-577FD5C5D771Q34524076-1579177C-35A6-48F6-99D3-1B5EDF027E74Q34565142-A6EDF6AE-BB5D-4DD4-B164-FD823EFEC79DQ36072693-700E5ACF-C179-42BE-A27F-50390896B3B4Q36274082-02C0966E-B50A-4BFD-BC73-26ACC7B50830Q36389340-ABFD84B7-DD31-4E5D-8FCA-3F22A0509D29Q36849571-2D060281-A229-4EEA-9560-2C5A841C711EQ36879298-B116E5BF-E9DD-4B3A-99F3-EF7E6AD1BE3FQ36907936-C88F45FA-1E00-4D51-A5AA-4E9E50F61B49Q37092498-1BBC4C50-C90F-4239-80A8-F16C4F68271FQ38381938-1C18270B-6D94-46BD-AFF5-4DCDBF634606Q38763927-4F298A0F-54C5-4145-8E5B-BBA477970196Q38843064-450AD041-39E8-47E1-9992-A212AB865258Q39524152-3A737F4D-B16E-43CA-815F-E83702E190FCQ40580982-8C31DBDE-41C3-4FFE-926F-99A490A076FDQ40902038-953699B2-A5C6-460E-A25D-D4EC9F553CB4Q40911930-DC255ED4-8B70-421B-9299-A8E429D10C2EQ41522083-2DE8953D-1C15-484E-B0B9-51254388A958Q41525185-D4C28FB0-744C-46DF-AD44-5143D114F811Q42208963-430BDBD3-8623-4E14-90D2-E936A5E7BD28Q42953393-B6310550-ADA5-4C3C-92F1-88ED837707A7Q43631750-83E46604-7E07-4141-A7D1-287AA7EC7101Q44708357-6971FCD6-CA76-4BA4-B4DB-5A9BA9C79CE0Q47390450-DF8383DE-A2E0-4729-A8D6-1E9B0839E0A3Q47892293-E8645921-C68E-41C4-B336-F42A005436ADQ47978062-D85E6F96-73DF-4AFC-8A57-71EADCA98FE9Q49737060-E131ECD3-69D6-4C35-9E39-1E5A7C1214D8Q50954501-FDC0DF42-4AC6-4EF5-A26B-D29FED1F2332Q50982861-9533EC25-C801-4453-842D-B670B07ECCF9Q55178518-3BD40778-18B9-426C-8166-4A0AE94BB52CQ55450355-46E858E9-338B-4FCE-80B4-25039854C8F5Q56355709-B483445C-4C9B-4EFC-9104-190BD91EA61AQ58128358-F16009EF-6302-43F3-82A2-14B3E68FD085
P2860
Evaluating walking in patients with multiple sclerosis: which assessment tools are useful in clinical practice?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluating walking in patients ...... e useful in clinical practice?
@en
Evaluating walking in patients ...... e useful in clinical practice?
@nl
type
label
Evaluating walking in patients ...... e useful in clinical practice?
@en
Evaluating walking in patients ...... e useful in clinical practice?
@nl
prefLabel
Evaluating walking in patients ...... e useful in clinical practice?
@en
Evaluating walking in patients ...... e useful in clinical practice?
@nl
P2860
P356
P1476
Evaluating walking in patients ...... e useful in clinical practice?
@en
P2093
Francois Bethoux
Susan Bennett
P2860
P356
10.7224/1537-2073-13.1.4
P577
2011-01-01T00:00:00Z